Developing products through sales partnerships without an MR team
First written in FY2017. 1 of 2 entries say "Restated". Latest entry: FY2018.
3 other companies' latest entry also says "Restated".
- FY2018RestatedAnnual report
「To concentrate management resources on research and development and manufacturing, our group does not have MRs (medical representatives) and does not conduct sales activities with medical institutions. Accordingly, for the generic drugs we develop, we partner on a product-by-product basis with pharmaceutical companies that have strong sales capabilities in the relevant therapeutic areas and commission them to conduct sales and promotional activities.」
It continues to operate a sales model without an MR team, concentrating on research and development and manufacturing and partnering with manufacturers with strong sales capabilities for each product. - FY2017First statedAnnual report
「To concentrate management resources on research and development and manufacturing, our group does not have MRs (medical representatives) and does not conduct sales activities with medical institutions. Accordingly, for the generic drugs we develop, we partner on a product-by-product basis with pharmaceutical companies that have strong sales capabilities in the relevant therapeutic areas and commission them to conduct sales and promotional activities.」
It records a sales model that concentrates management resources on research and development and manufacturing, while partnering with pharmaceutical companies with strong sales capabilities for each product.